SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001636282-24-000087
Filing Date
2024-11-07
Accepted
2024-11-07 16:14:57
Documents
6
Effectiveness Date
2024-11-07

Document Format Files

Seq Description Document Type Size
1 S-8 spyre-november2024xsx8.htm S-8 54238
2 EX-23.1 ex231pwcs-8consent.htm EX-23.1 1943
3 EX-99.1 ex9912018equityinducementp.htm EX-99.1 172581
4 EX-FILING FEES ex107feetablespyredraft102.htm EX-FILING FEES 35150
5 EX-5.1 ex51-gibsonopinion.htm EX-5.1 12992
6 GRAPHIC gibsonlogoa.jpg GRAPHIC 4668
  Complete submission text file 0001636282-24-000087.txt   284665
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-283065 | Film No.: 241435926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)